Concentrated dependencies, multi-site supply and regulated handoffs: supplier risk in life sciences is rarely a data problem — it is an ownership and governance problem. This page maps where continuity actually breaks.
01
Concentrated dependencies cascade.
Situation: multi-site supply with concentrated external dependencies. Risk: a single break cascades across markets. Intervention: resilience read of the operating model and cross-functional handoffs — see the global shipment resilience use case. Boundary: execution architecture — not demand planning or QP release.
02
The vendor master is a risk surface.
Vendor master data, controls and governance stabilized through the carve-out of Bayer Animal Health (Elanco).
Ownership per data domain instead of shared ambiguity.
Controls designed for audit reality — 12 P2P SoX controls developed and implemented.
03
When price risk becomes conduct risk.
Toyota Motor Europe (2012–2015): investigation champion in a wire-harness price-cartel case.
EUR 90M in savings via one-shot D&D payment versus piece-price — commercial structure used as a risk instrument.
Awarded for process value-added analysis.
04
Continuity through transformation.
Stabilization lead through a carve-out while the P2P organization moved from 30 to 17 experts.
A global power-user network — 130 power users, 35 captains, 35 countries — as continuity infrastructure.
Daily support operations without ticketing, through hypercare and beyond.
05
What a resilience read covers.
Operating model, ownership, handoffs, escalation paths and decision rights around your critical suppliers — named, bounded and decision-ready. The output is a read and a next step, not a software rollout.
06
The honest boundary.
These are employment and assignment contexts — publicly verifiable career facts, no current client relationships implied. Resilience reads support the continuity decision; they do not replace demand planning, quality or regulatory functions.